Issue: Prescription drugs
- Today: 10
- Past Seven Days: 36
- All-Time: 16,337
S.1699 - Prescription Drug Cost Reduction ActIntroduced Oct 12, 2011 (112th congress) 13 Views
A bill to reduce the costs of prescription drugs under the Medicare program, and for other purposes.
H.R.3150 - Medicare Safe Needle Disposal Coverage Act of 2011Introduced Oct 18, 2011 (112th congress) 3 Views
To amend title XVIII of the Social Security Act to provide for coverage, as supplies associated with the injection of insulin, of containment,...
H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011Introduced Sep 26, 2011 (112th congress) 8 Views
To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.
S.1584 - Drug Safety and Accountability Act of 2011Introduced Sep 20, 2011 (112th congress) 12 Views
A bill to provide for additional quality control of drugs.
H.R.2939 - Pharmaceutical Stewardship Act of 2011Introduced Sep 20, 2011 (112th congress) 12 Views
To provide for the disposal of drugs pursuant to national pharmaceutical stewardship programs, and for other purposes.
S.1560 - Nursing Home Resident Pain Relief Act of 2011Introduced Sep 14, 2011 (112th congress) 12 Views
A bill to enhance access to controlled substances for residents of institutional long-term care facilities, and for other purposes.
S.Res.261Senate Passed Sep 23, 2011 (112th congress) 2 Views
A resolution designating the month of October 2011 as "National Medicine Abuse Awareness Month".
S.1479 - Medicare Beneficiary Preservation of Choice Act of 2011Introduced Aug 02, 2011 (112th congress) 4 Views
A bill to preserve Medicare beneficiary choice by restoring and expanding Medicare open enrollment and disenrollment opportunities.
H.R.2674 - 340B Program Improvement ActIntroduced Aug 01, 2011 (112th congress) 42 Views
To amend section 340B of the Public Health Service Act to improve the provision of discounts on drug purchases for certain safety net providers.
H.R.2672 - Preserving Access to Orphan Drugs Act of 2011Introduced Aug 01, 2011 (112th congress) 10 Views
To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.